(Q34643499)

3 August 2017

Thymosin alpha 1: from bench to bedside (English)

1 reference

3 August 2017

Francesca Pica

3

0 references

Claudia Matteucci

Claudia Matteucci

Paola Sinibaldi Vallebona

6

0 references

Paola Sinibaldi Vallebona

4

0 references

Annalucia Serafino

Annalucia Serafino

8

0 references

Anna Teresa Palamara

Anna Teresa Palamara

5

0 references

Luigina Romani

Luigina Romani

11

0 references

Francesco Bistoni

10

Francesco Bistoni

1 reference

3 August 2017

Enrico Garaci

1

1 reference

3 August 2017

Cartesio Favalli

2

1 reference

3 August 2017

Pasquale Pierimarchi

7

1 reference

3 August 2017

Antonio Mastino

9

1 reference

3 August 2017

Guido Rasi

12

1 reference

3 August 2017

language of work or name

English

0 references

publication date

28 June 2007

1 reference

Annals of the New York Academy of Sciences

3 August 2017

1 reference

3 August 2017

1112

1 reference

3 August 2017

225-234

1 reference

Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level

3 August 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.044

Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.044

The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.044

Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.044

Interferon-alpha combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.044

Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.044

Thymosin 1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1415.044

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1415.044

1 reference

release_wd2vde5vjrhzfdaufkirrakqpi

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wd2vde5vjrhzfdaufkirrakqpi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference